Triapaptide stimulates bone formation and bone resorption, which can reduce the incidence of fracture in postmenopausal women. According to the different ways of administration, it can also increase or decrease bone mineral density. For primary osteoporosis, hypogonadic osteoporosis and postmenopausal osteoporosis.